European Registry Study on Lymphatic Interventions

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2026-02-01

Study Completion Date

2030-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This European multicenter observational study aims to evaluate the real-world use, timing, and outcomes of lymphatic interventions in patients with congenital heart disease and/or primary lymphatic disorders. The study will examine the effectiveness of diagnostic imaging and interventional techniques, such as lymphatic embolization, in improving clinical symptoms, biomarkers, and fluid-related complications. The central question is whether early diagnosis and targeted intervention can lead to clinically meaningful improvements and reduced need for reintervention. Data collected retrospectively and prospectively from participating centers will help identify predictors of outcome, assess disease severity, and inform standardized diagnostic and therapeutic pathways across Europe.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study Designed to Optimize the Treatment of Primary Pneumothorax

NCT02866305

Primary Spontaneous Pneumothorax Pleural Disease

UNKNOWN EARLY_PHASE1

The Role of Clamping Before Removal of a Pneumothorax Drain Connected to a Digital Drainage System.

NCT05180955

Pneumothorax and Air Leak

COMPLETED NA

EZ-blocker Versus Left Sided Double Lumen Tube in Adult Patients for Thoracic Surgery

NCT03403192

Thoracic Injuries

COMPLETED NA

Early Medical Thoracoscopy Versus Simple Chest Tube Drainage in Complicated Parapneumonic Effusion and Pleural Empyema

NCT00234208

Complicated Parapneumonic Effusion Pleural Empyema

TERMINATED PHASE3

Thoracentesis: Symptoms and Prediction of the Need for Therapeutic Thoracentesis

NCT04236934

Pleural Effusion Dyspnea Patient Reported Outcomes +2 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a prospective, multicenter observational study with retrospective components. The study population includes patients who have undergone or are undergoing lymphatic imaging diagnostics and lymphatic interventions at participating centers across Europe. Patients are included both retrospectively (from medical records) and prospectively as part of their routine clinical care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lymphatic Disorders Plastic Bronchitis Protein Losing Enteropathy Chylothorax Lymphatic Abnormalities

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Lymph intervention

Lymphatic intervention

Intervention Type PROCEDURE

This intervention was made as part of their clinical treatment.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lymphatic intervention

This intervention was made as part of their clinical treatment.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients of any age with a confirmed central lymphatic disorder, either in the context of CHD or as a primary lymphatic disorder, verified through lymphatic diagnostics (e.g. lymphatic imaging or relevant biomarkers).
* Patients who have undergone, or are undergoing, diagnostic lymphatic imaging and/or interventional procedures for their lymphatic disorder.
* Patients who are receiving, or have received, conservative (non-interventional) management for their lymphatic disorder.

Exclusion Criteria

* Patients with isolated peripheral lymphatic disorders not involving the central lymphatic system.
* Patients with acute postoperative iatrogenic chylothorax (\<3-4 weeks duration and not requiring intervention).
* Patients without sufficient clinical documentation to confirm diagnosis, treatment, or follow-up.
* Patients who decline, or whose legal guardians decline, to provide informed consent (for prospective inclusion).

Eligible Sex

ALL

Accepts Healthy Volunteers

No